CB
BMY.RT

Commerce Bank’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Commerce Bank’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-129,832
Closed -$90K – 1158
2020
Q4 		$90K Sell
129,832
-546
-0.4% -$1.16K ﹤0.01% 1063
2020
Q3 		$293K Sell
130,378
-16,306
-11% -$46.6K ﹤0.01% 865
2020
Q2 		$525K Sell
146,684
-937
-0.6% -$3.38K 0.01% 652
2020
Q1 		$561K Sell
147,621
-414
-0.3% -$1.36K 0.01% 552
2019
Q4 		$446K Buy
+148,035
New +$385K ﹤0.01% 679

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Commerce Bank's BMY.RT Position: Q1 2021 in Review

Commerce Bank sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 129,832 shares — an estimated $90K sold.

Commerce Bank first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $561K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Commerce Bank reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Commerce Bank sold 129,832 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $90K.
  • Commerce Bank first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Commerce Bank's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $561K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Commerce Bank's 13F filing for Q1 2021, filed 5 May 2021.